Compounds > dofequidar
Page last updated: 2024-09-05

dofequidar and Leukemia P388

dofequidar has been researched along with Leukemia P388 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baba, M; Fukazawa, N; Naito, M; Nakanishi, O; Sato, W; Suzuki, T; Tsuruo, T; Yano, O1
Tsuruo, T2

Reviews

2 review(s) available for dofequidar and Leukemia P388

ArticleYear
[Development of drugs to overcome drug resistance--basic approaches].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:3

    Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Drug Resistance, Multiple; Humans; Leukemia P388; Leukemia, Myeloid; Mice; Mice, Nude; Quinolines; Tumor Cells, Cultured; Verapamil

1995
[MDR reversing drugs for clinical development].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:7

    Topics: Animals; Antineoplastic Agents; Cyclosporins; Doxorubicin; Drug Resistance; Drug Synergism; Humans; Leukemia P388; Mice; Quinolines; Verapamil

1994

Other Studies

1 other study(ies) available for dofequidar and Leukemia P388

ArticleYear
Reversal of multidrug resistance by a novel quinoline derivative, MS-209.
    Cancer chemotherapy and pharmacology, 1995, Volume: 35, Issue:4

    Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Doxorubicin; Drug Resistance, Multiple; Female; Leukemia P388; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Quinolines; Tumor Cells, Cultured; Vincristine

1995